KaydedilenlerDerginizi ekleyin

Dergiler / Türkiye Acil Tıp Dergisi / 2007 / Cilt: 7 - Sayı: 1

The poisoned patient in the emergency department: An update on management

Frank LOVECCHIO
Dan QUAN
Sayfa
43–47
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

LOVECCHIO, F., QUAN, D. (2022). The poisoned patient in the emergency department: An update on management. Türkiye Acil Tıp Dergisi, Cilt: 7 - Sayı: 1, 43–47. https://ajindex.com/articles/626165

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Krenzelok EP, McGuigan M, Lheur P. Position statement: ipecac syrup. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997;35:699-709. American Academy of Pediatrics. Policy statement: poison treatment in the home. Pediatrics 2003; 112:1182-5.
  2. Manno BR, Manno JE: Toxicology of ipecac: areview. Clin Toxicol 1997; 10:221-42.
  3. Schneider DJ, Perez A, Knilans TE: Clinical and pathological aspects of cardiomyopathy from ipecac administration in Munchausen's syndrome by proxy. Pediatrics 1996;97:902-6.
  4. Mateer JE, Farrell BJ, Chou SM. Reversible ipecac myopathy. Arch Neurol 1985;42:188-90. Anderson H. Experimental studies on the pharmacology of activated charcoal. I. Adsorption power of charcoal in aqueous solutions. Acta Pharmacol 1946;2:69- 78. Gaudreault P. Activated charcoal revisited. Clin Ped Emerg Med 2005;(6):76-80.
  5. Chin L, Picchioni AL, Bourn WM, Laird HE. Optimal antidotal dose of activated charcoal. Toxicol Appl Pharmacol 1973;26:103-8. Olkkola KT. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man. Br J Clin Pharmacol 1985;19:767-73.
  6. Tsuchiya T, Levy G. Relationship between effect of activated charcoal on drug absorption in man and its drug adsorption characteristics in vitro. J Pharm Sci 1972;61:586-9.
  7. Chyka PA, Seger D, Krenzelok EP, Vale JA. Position paper: single-dose activated charcoal. Clin Toxicol 2005,43:61-87. Cooney DO. Activated charcoal in medical applications. New York: Marcel Dekker; 1995.
  8. Merigian KS, Woodard M, Hedges JR, Roberts JR, Stuebing R, Rashkin MC. Prospective evaluation of gastric emptying in the selfpoisoned patient. Am J Emerg Med 1990;8:479-83.
  9. Kornberg AE, Dolgin J. Pediatric ingestions: charcoal alone versus ipecac and charcoal. Ann Emerg Med 1991;20:648-51.
  10. Kulig K, Bar-Or D, Cantrill SV, Rosen P, Rumack BH. Management of acutely poi­ soned patients without gastric emptying. Ann Emerg Med 1985; 14:562-7.
  11. Albertson TE, Derlet RW, Foulke GE, Minguillon MC, Tharratt SR. Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treat­ment of toxic ingestions. Ann Emerg Med 1989;18:56-9.
  12. Bosse GM, Barefoot JA, Pfeifer MP, Rodgers GC. Comparison of three methods of gut decontamination in tricyclic antidepressant overdose. J Emerg Med 1995; 13:203-9.
  13. Pond SM, Lewis-Driver DJ, Williams GM, Green AC, Stevenson NW. Gastric emptying in acute overdose: a prospective randomized controll